Symbols

MDAI

Spectral AI·NASDAQ

--(--)

MDAI fundamentals

MDAI Q4 2025 Earnings

Spectral AI (MDAI) released its earnings on Mar 24, 2026: revenue was 3.85M (YoY -49.38%), beat estimates; EPS was 0.02 (YoY +104.88%), beat estimates.

Revenue / YoY

3.85M

-49.38%

EPS / YoY

0.02

+104.88%

Report date

Mar 24, 2026

MDAI Earnings Call Summary for Q4,2025

FDA Milestone: Anticipated Q2 2026 response on De Novo application for DeepView system.
BARDA Support: $31.7 million funding to accelerate development, with 170 subsidized systems deployed by 2027.
Financial Strength: $15 million cash at year-end, 2026 revenue guidance of $18.5 million.
Commercialization Timeline: Initial placements in late 2026, significant revenue growth in 2027-2028.
International Expansion: Targeting U.K., Australia, and GCC nations post-FDA approval.

Earnings

EPS

Revenue

Revenue & Expenses

MDAI has released its 2025 Q3 earnings report, with revenue of 3.79M, reflecting a YoY change of -53.60%, and net profit of -3.55M, showing a YoY change of -136.17%. The Sankey diagram below clearly presents MDAI's revenue sources and cost distribution.

Key Indicators

Spectral AI (MDAI) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Spectral AI (MDAI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Spectral AI (MDAI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Spectral AI (MDAI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown